Trends in Real-World Neovascular AMD Treatment Outcomes in the UK.

Hemal MehtaLeah N KimThibaud MathisPardis Zalmay Faruque D GhanchiWinfried M AmoakuLaurent Kodjikian

Published in: Clinical ophthalmology (Auckland, N.Z.) (2020)

UK real-world outcomes have improved over the last decade with improved service delivery and the adoption of more proactive treatment regimens but are still not always as impressive as registration clinical trial results. Access to longer-acting anti-VEGF therapies would reduce the treatment burden for patients, carers, and the healthcare system, potentially making replication of clinical trial results possible in the NHS.

Keyphrases

clinical trial
end stage renal disease
mental health
chronic kidney disease
vascular endothelial growth factor
cross sectional
age related macular degeneration
endothelial cells
phase ii
patient safety
prognostic factors
open label
peritoneal dialysis
study protocol
combination therapy
patient reported outcomes